Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) Other Non Operating Income (2016 - 2024)

Apyx Medical filings provide 15 years of Other Non Operating Income readings, the most recent being -$163000.0 for Q4 2024.

  • On a quarterly basis, Other Non Operating Income rose 95.61% to -$163000.0 in Q4 2024 year-over-year; TTM through Jun 2025 was -$139000.0, a 96.29% increase, with the full-year FY2024 number at -$161000.0, up 94.79% from a year prior.
  • Other Non Operating Income hit -$163000.0 in Q4 2024 for Apyx Medical, down from $24000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $636000.0 in Q1 2020 to a low of -$3.7 million in Q4 2023.
  • Median Other Non Operating Income over the past 5 years was -$20000.0 (2023), compared with a mean of -$174700.0.
  • Biggest five-year swings in Other Non Operating Income: soared 760.0% in 2021 and later crashed 596.3% in 2023.
  • Apyx Medical's Other Non Operating Income stood at $131000.0 in 2020, then crashed by 240.46% to -$184000.0 in 2021, then tumbled by 243.48% to -$632000.0 in 2022, then tumbled by 487.03% to -$3.7 million in 2023, then soared by 95.61% to -$163000.0 in 2024.
  • The last three reported values for Other Non Operating Income were -$163000.0 (Q4 2024), $24000.0 (Q3 2024), and -$1000.0 (Q2 2024) per Business Quant data.